Search Results
Sep 10, 2026, 09:05 ET Academy Sports + Outdoors is the Destination for Premium Performance Running with Launch of Hoka
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, announced today it is launching
More news about: Academy Sports + Outdoors
Sep 08, 2026, 09:05 ET Academy Sports + Outdoors Announces Participation in Upcoming Investor Conference
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today announced its participation in the upcoming Goldman Sachs 33rd Annual Global
More news about: Academy Sports + Outdoors
Sep 04, 2026, 09:05 ET Academy Sports + Outdoors Announces Quarterly Cash Dividend
Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (Nasdaq: ASO) announced today that on September 2, 2026, its Board of Directors declared a quarterly cash dividend of $0.15 per share of the Company's common stock
More news about: Academy Sports + Outdoors
Sep 03, 2026, 09:05 ET Academy Sports + Outdoors Announces Executive Appointment
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today announced the appointment of Matthew (Matt) M. Pasch to the role of Executive
More news about: Academy Sports + Outdoors
Aug 31, 2026, 14:00 ET Academy Sports + Outdoors is the Ultimate Tailgating Fan Shop
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is kicking off football season with its
More news about: Academy Sports + Outdoors
Aug 31, 2026, 10:15 ET Oligonucleotide CDMO Market worth $11.14 billion by 2031 - Exclusive Report by MarketsandMarkets™
companies are increasingly outsourcing synthesis, purification, analytical testing, and commercial-scale production to specialized CDMOs. The advancement of ASO and siRNA programs across clinical and commercial stages is further increasing demand for scalable manufacturing capabilities. The growing complexity
More news about: MarketsandMarkets
Aug 28, 2026, 15:44 ET Academy Sports + Outdoors Teams Up with Nike and Jordan Brand to Present the H-Town Classic 3v3 Basketball Tournament
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, in partnership with
More news about: Academy Sports + Outdoors
Aug 27, 2026, 20:00 ET AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
AHB-137AHB-137 is AusperBio's lead investigational unconjugated antisense oligonucleotide (ASO) therapy for chronic hepatitis B (CHB), developed using the Company's proprietary Med-Oligo™ ASO platform. AHB-137 is designed to suppress hepatitis B surface antigen (HBsAg) production,
More news about: AusperBio Therapeutics Inc.
Aug 26, 2026, 08:55 ET Academy Sports + Outdoors Announces Second Quarter Fiscal 2026 Results Conference Call
Academy Sports and Outdoors, Inc. ("Academy" or the "Company") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, plans to release its second quarter fiscal 2026 financial results before the market
More news about: Academy Sports + Outdoors
Aug 25, 2026, 10:15 ET Peptide Synthesis Market worth $1.54 billion by 2031 - Exclusive Report by MarketsandMarkets™
Oligonucleotide Synthesis Market by Offerings (Synthesis products [Consumables, Equipment], Synthesized Oligos (Type [DNA, RNA], Oligo-based Drugs (Type [ASO, siRNA), Therapy Area [Rare Diseases, Neurology, Oncology], Competition - Global Forecast to 2031
More news about: MarketsandMarkets
Aug 25, 2026, 09:00 ET Academy Sports + Outdoors and Ariat International Expand Partnership with 200 New In-Store Shops this Fall
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today announced it has teamed up with
More news about: Academy Sports + Outdoors
Aug 24, 2026, 03:01 ET ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
research and co-development to identify CNS-targeted drug candidates by utilizing LNP technologies with various modalities, including mRNA, siRNA, and ASO. We are already receiving interest from global companies and are currently discussing collaborative research with multiple companies.""We will
More news about: ImmunoForge Co., Ltd.
Aug 18, 2026, 09:05 ET Academy Sports + Outdoors Fuels Growth with Eleven New Stores Opening Across Six States in Q3
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce it has opened two new stores in
More news about: Academy Sports + Outdoors
Aug 10, 2026, 09:00 ET Instacart and Academy Sports + Outdoors Team Up for Same-Day Delivery in as Fast as an Hour
Academy Sports + Outdoors ("Academy") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer. The partnership brings Academy's broad catalog to the Instacart Marketplace, giving
More news about: Maplebear Inc. dba Instacart
Aug 06, 2026, 16:03 ET BioMarin Reports Second Quarter 2026 Financial and Operating Results
BioMarin and the n-Lorem Foundation entered a collaboration and global exclusive license agreement to develop a first-in-disease antisense oligonucleotide (ASO) medicine for ReNU syndrome, a serious, rare neurodevelopmental condition with no approved targeted therapies. ReNU syndrome has an expected global population
More news about: BioMarin Pharmaceutical Inc.
Aug 06, 2026, 07:00 ET Evolent Announces Second Quarter 2026 Results
FeePerformance Suite Lives on Platform are calculated by summing monthly members covered for specialty care services for contracts not under ASO arrangements divided by the number of months in the period. Specialty Technology and Services Suite Lives on Platform are calculated by summing monthly
More news about: Evolent Health, Inc.
Aug 03, 2026, 05:30 ET AusperBio Announces First Patient Dosed in Clinical Study of Investigational HBV Candidate AHB-171
to develop proprietary platform technologies and translate them into clinical-stage assets. AHB-171 expands AusperBio's HBV pipeline beyond the lead ASO AHB-137 program and reinforces our strategy of developing differentiated oligonucleotide therapeutics with complementary mechanisms of action for the
More news about: AusperBio Therapeutics Inc.
Jul 30, 2026, 09:05 ET Academy Sports + Outdoors Advances Omnichannel Growth Strategy with Launch of Academy Retail Media
Academy Sports + Outdoors ("Academy") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today launched Academy Retail Media (ARM) as the next evolution of its omnichannel
More news about: Academy Sports + Outdoors
Jul 29, 2026, 11:05 ET Academy Sports + Outdoors Partners with French Toast and BEAR to Support 1,000 Houston-area Students During Back-to-School Season
Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO) teamed up with leading school wear brand
More news about: Academy Sports + Outdoors
Jul 29, 2026, 10:07 ET GENESIS AND GENESIS INSPIRATION FOUNDATION INVEST IN YOUTH DEVELOPMENT AND STEAM LEARNING ACROSS THE WASHINGTON METROPOLITAN AREA
and performance opportunities that foster artistic excellence and celebrate the value of every voice.Alexandria Symphony Orchestra: ASO Sympatico, a partnership between the Alexandria Symphony Orchestra and Alexandria City Public Schools, provides free, inclusive music education that
More news about: Genesis Motor America
Jul 29, 2026, 09:57 ET Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms
small molecules and monoclonal antibodies. However, traditional RNA therapeutics have been largely limited to gene-silencing approaches (siRNA and ASO).As the global pioneer in RNA activation (RNAa), Ractigen was founded to redefine genetic medicine by enabling precise gene activation.
More news about: Ractigen Therapeutics
Jul 28, 2026, 14:05 ET Academy Sports + Outdoors Helps Texas Families Kick Off Back-to-School and Back-to-Sport Shopping with Exclusive Statewide Giveaway Event
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is making Back-to-School and Back-to-Sport shopping for Texas families even easier.
More news about: Academy Sports + Outdoors
Jul 27, 2026, 09:05 ET BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
hope to these nano-rare patients by developing individualized ASO medicines, which are short strands of modified DNA that can specifically target the transcripts of a defective gene to correct the abnormality. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and
More news about: BioMarin Pharmaceutical Inc.
Jul 23, 2026, 09:05 ET Academy Sports + Outdoors Helps Families Win Back-to-School and Back-to-Sport with Thousands of Lower Prices on Brands Families Know and Trust
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is helping families make the most of the back-to-school season for less with a
More news about: Academy Sports + Outdoors
Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™
their versatility in modulating gene expression, treating rare genetic disorders, and addressing oncology targets. Regulatory approvals for landmark ASO therapies, such as Nusinersen for spinal muscular atrophy and Inotersen for hereditary ATTR amyloidosis, have driven both analyst and investor confidence,
More news about: MarketsandMarkets